Muawyah Al Bdour | Ophthalmology | Best Researcher Award

Prof. Muawyah Al Bdour | Ophthalmology | Best Researcher Award

Prof. Muawyah Al Bdour, The University of Jordan, Jordan

Prof. Muawyah Dawoud Al Bdour, MBBS, FRCSI (Ophth), is a distinguished Consultant Ophthalmologist and Professor at the Faculty of Medicine, University of Jordan, and serves as Director of the Jordan Eye Bank. Born in 1963, Prof. Al Bdour graduated with distinction from the University of Jordan and earned his Fellowship in Ophthalmology from the Royal College of Surgeons in Ireland. With over three decades of expertise, he has held key academic and administrative positions, including Dean of the Faculty of Medicine, Chairman of Ophthalmology and Special Surgery Departments, and President of the Arab Board of Ophthalmology. He has been instrumental in establishing national and international ophthalmic assessment centers and has played a central role in training, examination, and curriculum development across the Arab world. Prof. Al Bdour has served on editorial boards of multiple medical journals and contributed significantly to national health policy and blindness prevention. He has been an active member in over 60 committees and councils and continues to lead initiatives in diabetic retinopathy, organ donation, and eye banking. Internationally recognized for his contributions, he remains a driving force in ophthalmology education, research, and public health both in Jordan and the wider region.

Publication Profile

Google Scholar

Academic and Medical Qualifications

Prof. Muawyah Al Bdour possesses a distinguished academic background reflecting both scholastic excellence and medical proficiency. He ranked 7th nationwide in Jordan upon completing his General Secondary Education Certificate in July 1981 with an “Excellent” grade. His proficiency in English was further validated by a high TOEFL score of 253 (computer-based), equivalent to 610 (paper-based), achieved in September 2000. He pursued his medical education at the University of Jordan, earning his M.B.B.S degree in June 1987 with a “Very Good” grade and ranking 6th among medical graduates after completing a rigorous six-year program. Licensed to practice medicine in Jordan since May 1988, Prof. Al Bdour demonstrated his global medical competence by obtaining the prestigious ECFMG Certificate from the United States in October 1990 after successfully passing the Basic, Clinical, and English components of the FMGEMS. His specialization in ophthalmology was marked by the awarding of the F.R.C.S.I. (Ophthalmology) by the Royal College of Surgeons in Ireland in July 1995. This was further recognized with a Certificate of Specialization in Ophthalmology issued by the Jordan Medical Council in November 1995. These qualifications collectively highlight Prof. Al Bdour’s academic rigor and professional credibility in the field of ophthalmology.

Professional Appointments and Leadership Roles

Prof. Muawyah Al Bdour currently serves as a Professor and Consultant in the Ophthalmology Division at Jordan University Hospital and as Director of the Jordan Eye Bank in Amman. His medical career began as an intern at Jordan University Hospital (1987–1988), followed by a role as a General Practitioner at the Royal Medical Services (1988–1989). He then pursued residency training in ophthalmology at both King Hussein Medical Center (1989–1992) and Jordan University of Science & Technology (1992–1993), before becoming a Registrar at the University of Aberdeen in the UK (1993–1995). He returned to Jordan as an Assistant Professor and Consultant (1995–2001), advancing to Associate Professor and Chairman of the Ophthalmology Division at Jordan University of Science & Technology. From 2004 onward, Prof. Al Bdour held progressive academic and clinical leadership roles at Jordan University Hospital, including Chairman of Ophthalmology and Special Surgery Departments, culminating in his appointment as Dean of the Faculty of Medicine at the University of Jordan (2013–2015). He also served as President of the Arab Board of Ophthalmology (2019–2023). Throughout his career, Prof. Al Bdour has demonstrated a consistent commitment to advancing ophthalmic education, clinical excellence, and healthcare leadership both nationally and regionally.

Research Focus

Prof. Muawyah Al Bdour’s research is deeply rooted in ophthalmology, with a primary focus on corneal diseases, diabetic eye complications, refractive errors, ocular trauma, and public health ophthalmology. His studies span crucial areas such as the epidemiology of refractive errors and visual impairment, with notable work on the prevalence and risk factors of diabetic retinopathy and blindness in Jordanian populations. He has significantly contributed to the understanding of keratoconus, pseudoexfoliation syndrome, and ocular biometry. A recurring theme in his research includes clinical outcomes of advanced corneal interventions, such as intrastromal corneal ring segments and intravitreal anti-VEGF therapies. Furthermore, Prof. Al Bdour has investigated the impact of systemic diseases on ocular health, such as multiple sclerosis and autoimmune conditions. His role in public health is evident in collaborative projects targeting diabetic eye disease screening and blindness prevention across Jordan. His publications, often cited and internationally recognized, reflect a balanced contribution to both clinical ophthalmic advancements and public health strategies. With over 1800 citations and decades of scholarly output, Prof. Al Bdour’s research bridges clinical excellence, community-based healthcare, and ophthalmic education, solidifying his role as a leading expert in Middle Eastern and global ophthalmology.

Publication Top Notes

📘 Refractive error and ocular biometry in Jordanian adults – Cited by 186, 📅 2005
🧪 Mesenchymal stem cells & conditioned media in MS treatment – Cited by 148, 📅 2017
🌞 Risk factors for pterygium in adult Jordanians – Cited by 109, 📅 2004
👁 KeraRing segments for keratoconus correction – Cited by 85, 📅 2012
🧒 Childhood eye injuries in North Jordan – Cited by 68, 📅 1998
🔍 Blindness & diabetic retinopathy in northern Jordan – Cited by 67, 📅 2015
💉 Risk factors for diabetic retinopathy in Jordanians – Cited by 67, 📅 2008
📉 Visual impairment among Jordanian diabetics – Cited by 61, 📅 2005
🦠 Anti-VEGF delay during COVID-19 lockdown – Cited by 53, 📅 2021
📊 DR prevalence in type 2 diabetes patients in Jordan – Cited by 47, 📅 2008
🏥 Causes of blindness in adult Jordanians (hospital-based) – Cited by 36, 📅 2002
🌀 Keratoconus at Jordan University Hospital – Cited by 35, 📅 2012
Pseudoexfoliation syndrome at JU Hospital – Cited by 34, 📅 2008
📚 Myopia and education level correlation – Cited by 28, 📅 2001
🔬 Autoimmune thyroid disease & keratoconus link – Cited by 26, 📅 2018
🧍 Ankylosing spondylitis in North Jordan – Cited by 25, 📅 2000
🔺 Topographic features of keratoconus in Jordanians – Cited by 24, 📅 2014
💉 Intravitreal Bevacizumab for ocular neovascularization – Cited by 22, 📅 2013
🔎 Biomicroscopy vs fluorescein angiography in DR – Cited by 21, 📅 2007

Pierre-Jean Pintard | Ophthalmology | Best Industrial Research Award

Dr. Pierre-Jean Pintard | Ophthalmology | Best Industrial Research Award

Medical Director at Abbvie, United Kingdom

👨‍⚕️ Dr. Pierre-Jean Pintard is a multilingual Medical Doctor based in London 🇬🇧, with expertise in Clinical Development, Medical Affairs, HEOR, and Pharmacovigilance. Currently Associate Global Medical Director at AbbVie, he has held key roles at Gilead, Bial, and Mylan. He holds an MD from Barts and The London, an MSc in Health Economics from LSE & LSHTM, and specialty training in Pharmaceutical Medicine. He has published in top journals and presented internationally. Fluent in French 🇫🇷, English 🇬🇧, and Spanish 🇪🇸, he is also a pianist 🎹 and certified sailing instructor ⛵.

Publication Profile

Google Scholar

Professional Experience

Dr. Pierre-Jean Pintard is a seasoned global medical leader with extensive experience across top pharmaceutical companies. Currently serving as Associate Global Medical Director at AbbVie 🌐, he leads clinical strategies and evidence generation for Ozurdex. At Gilead Sciences 🇪🇺, he played a pivotal role in maintaining access to Ambisome and launching Epclusa. Previously at Bial 🇵🇹, he managed global medical affairs for the inflammation portfolio. At Mylan 🇬🇧, he launched biosimilars and provided expert medical insights. Earlier roles at Bristol Myers Squibb and William Harvey Institute honed his skills in health outcomes research and clinical science 🔬📊

🎓 Educational Background

Dr. Pierre-Jean Pintard holds a diverse and interdisciplinary academic background. He completed Pharmaceutical Medicine Specialty Training (2019–2020) at NOVA Medical School/University of Aveiro, gaining expertise in protocol design, data analysis, and clinical monitoring 📊. He earned an MSc in International Health Economics and Policy (2016–2017) from LSE & LSHTM, focusing on pharma economics and cost-effectiveness 💶. His MD in Medicine (2011–2015) from Barts and the London included an elective in Kenya 🇰🇪 and a poster presentation at SCMR Nice. He also holds a BSc in Biomedical Sciences (2008–2011) from Queen Mary University, with emphasis on clinical trials and drug design 💊.

💼 Skills & Personal Interests

Dr. Pierre-Jean Pintard is a multilingual professional, fluent in French 🇫🇷 and English 🇬🇧, with proficiency in Spanish 🇪🇸 (C1), and basic knowledge of Portuguese 🇵🇹 and German 🇩🇪 (A2). His technical skills include MS Word, Excel (with Markov models), STATA, Zinc, Epi-Info, and Spotfire 💻. A passionate musician, he studied piano for 9 years at the Conservatoire of Marseille and earned 3rd prize at the Steinway & Sons championship 🎹. He is also an avid sailor ⛵ with 13 years of experience at Marseille Yachting Club and Docklands Sailing Centre, holding a sailing instructor license.

Research Focus

Dr. Pierre-Jean Pintard’s research spans across psychiatry, ophthalmology, and cardiology, reflecting a multidisciplinary focus. His early work explored mental health stigma among medical students 🧠. He has significantly contributed to ophthalmic research, especially in diabetic macular edema, identifying macular volume as a surrogate marker for visual acuity 👁️📊. In cardiology, he co-authored a study comparing cardiac MRI techniques for assessing left atrial volume, enhancing diagnostic precision ❤️🧲. His expertise lies in biomarker identification, clinical imaging, and evidence synthesis, highlighting a strong foundation in clinical research and health outcomes across multiple therapeutic areas.

Conclusion

Dr. Pierre-Jean Pintard is highly suitable for the Research for Best Industrial Research Award.
His industrially relevant clinical research, cross-functional leadership, international collaboration, and proven ability to drive patient-centric innovations align with the award’s objectives.

Publication Top Notes

📘 Medical students’ attitudes about mental illness – PJ Pintard et al. – 🗓️ 2012 – 📊 Cited by: 3 – 🧠🩺
📘 Anatomic biomarkers in diabetic macular edema: Macular volume as a surrogate for visual acuity – PJ Pintard et al. – 🗓️ 2025 – 📊 Cited by: [Data Pending] – 👁️📈
📘 Cardiac MRI techniques for left atrial volume measurement – PJ Pintard et al. – 🗓️ 2015 – 📊 Cited by: [Not Specified] – ❤️🧲